nodes	percent_of_prediction	percent_of_DWPC	metapath
Emtricitabine—Zalcitabine—CYP3A43—prostate cancer	0.00773	0.294	CrCbGaD
Emtricitabine—Decitabine—DNMT1—prostate cancer	0.00588	0.223	CrCbGaD
Emtricitabine—Floxuridine—TYMS—prostate cancer	0.0048	0.182	CrCbGaD
Emtricitabine—DCK—prostate gland—prostate cancer	0.00386	0.264	CbGeAlD
Emtricitabine—DCK—Estradiol valerate/Dienogest—Estrone—prostate cancer	0.00384	0.172	CbGdCrCtD
Emtricitabine—DCK—seminal vesicle—prostate cancer	0.00327	0.223	CbGeAlD
Emtricitabine—DCK—Fulvestrant—Estradiol—prostate cancer	0.0031	0.139	CbGdCrCtD
Emtricitabine—Lamivudine—SLC22A3—prostate cancer	0.003	0.114	CrCbGaD
Emtricitabine—DCK—Estradiol valerate/Dienogest—Estradiol—prostate cancer	0.00291	0.13	CbGdCrCtD
Emtricitabine—DCK—Estradiol valerate/Dienogest—Ethinyl Estradiol—prostate cancer	0.00284	0.127	CbGdCrCtD
Emtricitabine—DCK—Levorphanol—Estrone—prostate cancer	0.00271	0.121	CbGdCrCtD
Emtricitabine—DCK—urethra—prostate cancer	0.00259	0.177	CbGeAlD
Emtricitabine—Lamivudine—SLC22A1—prostate cancer	0.00215	0.0817	CrCbGaD
Emtricitabine—DCK—Levorphanol—Estradiol—prostate cancer	0.00205	0.0919	CbGdCrCtD
Emtricitabine—DCK—bone marrow—prostate cancer	0.00199	0.136	CbGeAlD
Emtricitabine—Zalcitabine—CYP3A5—prostate cancer	0.00194	0.0736	CrCbGaD
Emtricitabine—DCK—testis—prostate cancer	0.0017	0.116	CbGeAlD
Emtricitabine—DCK—Doxorubicin—Epirubicin—prostate cancer	0.00143	0.0639	CbGdCrCtD
Emtricitabine—DCK—Epirubicin—Doxorubicin—prostate cancer	0.00132	0.0591	CbGdCrCtD
Emtricitabine—DCK—lymph node—prostate cancer	0.00123	0.0842	CbGeAlD
Emtricitabine—DCK—Levonorgestrel—Ethinyl Estradiol—prostate cancer	0.000972	0.0435	CbGdCrCtD
Emtricitabine—Zalcitabine—CYP3A4—prostate cancer	0.000839	0.0319	CrCbGaD
Emtricitabine—DCK—Desoximetasone—Prednisone—prostate cancer	0.000584	0.0262	CbGdCrCtD
Emtricitabine—DCK—Diflorasone—Prednisone—prostate cancer	0.000567	0.0254	CbGdCrCtD
Emtricitabine—Back pain—Capecitabine—prostate cancer	0.000392	0.000418	CcSEcCtD
Emtricitabine—Breast disorder—Doxorubicin—prostate cancer	0.000392	0.000418	CcSEcCtD
Emtricitabine—Hypersensitivity—Estradiol—prostate cancer	0.00039	0.000417	CcSEcCtD
Emtricitabine—Abdominal pain—Mitoxantrone—prostate cancer	0.00039	0.000417	CcSEcCtD
Emtricitabine—Body temperature increased—Mitoxantrone—prostate cancer	0.00039	0.000417	CcSEcCtD
Emtricitabine—Nasopharyngitis—Doxorubicin—prostate cancer	0.000388	0.000414	CcSEcCtD
Emtricitabine—Anaemia—Docetaxel—prostate cancer	0.000387	0.000413	CcSEcCtD
Emtricitabine—Alanine aminotransferase increased—Doxorubicin—prostate cancer	0.000382	0.000408	CcSEcCtD
Emtricitabine—Muscular weakness—Doxorubicin—prostate cancer	0.000382	0.000408	CcSEcCtD
Emtricitabine—Asthenia—Estradiol—prostate cancer	0.00038	0.000406	CcSEcCtD
Emtricitabine—Neutropenia—Epirubicin—prostate cancer	0.000379	0.000404	CcSEcCtD
Emtricitabine—Upper respiratory tract infection—Epirubicin—prostate cancer	0.000376	0.000402	CcSEcCtD
Emtricitabine—Pruritus—Estradiol—prostate cancer	0.000375	0.0004	CcSEcCtD
Emtricitabine—Anaemia—Capecitabine—prostate cancer	0.000374	0.0004	CcSEcCtD
Emtricitabine—Immune system disorder—Prednisone—prostate cancer	0.000374	0.0004	CcSEcCtD
Emtricitabine—Paraesthesia—Etoposide—prostate cancer	0.000369	0.000394	CcSEcCtD
Emtricitabine—Pancreatitis—Doxorubicin—prostate cancer	0.000367	0.000392	CcSEcCtD
Emtricitabine—Weight decreased—Epirubicin—prostate cancer	0.000366	0.000391	CcSEcCtD
Emtricitabine—Dyspnoea—Etoposide—prostate cancer	0.000366	0.000391	CcSEcCtD
Emtricitabine—Hyperglycaemia—Epirubicin—prostate cancer	0.000365	0.00039	CcSEcCtD
Emtricitabine—Cough—Docetaxel—prostate cancer	0.000365	0.00039	CcSEcCtD
Emtricitabine—Hypersensitivity—Mitoxantrone—prostate cancer	0.000364	0.000388	CcSEcCtD
Emtricitabine—Pneumonia—Epirubicin—prostate cancer	0.000363	0.000388	CcSEcCtD
Emtricitabine—Mental disorder—Prednisone—prostate cancer	0.000363	0.000388	CcSEcCtD
Emtricitabine—Diarrhoea—Estradiol—prostate cancer	0.000363	0.000387	CcSEcCtD
Emtricitabine—Infestation NOS—Epirubicin—prostate cancer	0.000361	0.000385	CcSEcCtD
Emtricitabine—Infestation—Epirubicin—prostate cancer	0.000361	0.000385	CcSEcCtD
Emtricitabine—Malnutrition—Prednisone—prostate cancer	0.000361	0.000385	CcSEcCtD
Emtricitabine—Arthralgia—Docetaxel—prostate cancer	0.000356	0.00038	CcSEcCtD
Emtricitabine—Myalgia—Docetaxel—prostate cancer	0.000356	0.00038	CcSEcCtD
Emtricitabine—Renal failure—Epirubicin—prostate cancer	0.000355	0.000379	CcSEcCtD
Emtricitabine—Gastrointestinal disorder—Etoposide—prostate cancer	0.000355	0.000379	CcSEcCtD
Emtricitabine—Asthenia—Mitoxantrone—prostate cancer	0.000354	0.000378	CcSEcCtD
Emtricitabine—Fatigue—Etoposide—prostate cancer	0.000354	0.000378	CcSEcCtD
Emtricitabine—Neuropathy peripheral—Epirubicin—prostate cancer	0.000354	0.000378	CcSEcCtD
Emtricitabine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—prostate cancer	0.000354	0.000378	CcSEcCtD
Emtricitabine—Cough—Capecitabine—prostate cancer	0.000353	0.000377	CcSEcCtD
Emtricitabine—Pain—Etoposide—prostate cancer	0.000351	0.000375	CcSEcCtD
Emtricitabine—Urinary tract infection—Epirubicin—prostate cancer	0.000351	0.000375	CcSEcCtD
Emtricitabine—Dizziness—Estradiol—prostate cancer	0.00035	0.000374	CcSEcCtD
Emtricitabine—Neutropenia—Doxorubicin—prostate cancer	0.00035	0.000374	CcSEcCtD
Emtricitabine—Upper respiratory tract infection—Doxorubicin—prostate cancer	0.000348	0.000372	CcSEcCtD
Emtricitabine—Arthralgia—Capecitabine—prostate cancer	0.000345	0.000368	CcSEcCtD
Emtricitabine—Myalgia—Capecitabine—prostate cancer	0.000345	0.000368	CcSEcCtD
Emtricitabine—Haematuria—Epirubicin—prostate cancer	0.000344	0.000367	CcSEcCtD
Emtricitabine—Anxiety—Capecitabine—prostate cancer	0.000344	0.000367	CcSEcCtD
Emtricitabine—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—prostate cancer	0.000342	0.000366	CcSEcCtD
Emtricitabine—Hepatobiliary disease—Epirubicin—prostate cancer	0.000341	0.000365	CcSEcCtD
Emtricitabine—Infection—Docetaxel—prostate cancer	0.000339	0.000362	CcSEcCtD
Emtricitabine—Weight decreased—Doxorubicin—prostate cancer	0.000339	0.000362	CcSEcCtD
Emtricitabine—Sinusitis—Epirubicin—prostate cancer	0.000339	0.000362	CcSEcCtD
Emtricitabine—Hyperglycaemia—Doxorubicin—prostate cancer	0.000338	0.000361	CcSEcCtD
Emtricitabine—Diarrhoea—Mitoxantrone—prostate cancer	0.000338	0.000361	CcSEcCtD
Emtricitabine—Vomiting—Estradiol—prostate cancer	0.000337	0.00036	CcSEcCtD
Emtricitabine—Pneumonia—Doxorubicin—prostate cancer	0.000336	0.000359	CcSEcCtD
Emtricitabine—Gastrointestinal pain—Etoposide—prostate cancer	0.000336	0.000359	CcSEcCtD
Emtricitabine—Nervous system disorder—Docetaxel—prostate cancer	0.000335	0.000357	CcSEcCtD
Emtricitabine—Thrombocytopenia—Docetaxel—prostate cancer	0.000334	0.000357	CcSEcCtD
Emtricitabine—Rash—Estradiol—prostate cancer	0.000334	0.000357	CcSEcCtD
Emtricitabine—Infestation NOS—Doxorubicin—prostate cancer	0.000334	0.000357	CcSEcCtD
Emtricitabine—Infestation—Doxorubicin—prostate cancer	0.000334	0.000357	CcSEcCtD
Emtricitabine—Dermatitis—Estradiol—prostate cancer	0.000334	0.000356	CcSEcCtD
Emtricitabine—Anaemia—Prednisone—prostate cancer	0.000333	0.000356	CcSEcCtD
Emtricitabine—Headache—Estradiol—prostate cancer	0.000332	0.000354	CcSEcCtD
Emtricitabine—Skin disorder—Docetaxel—prostate cancer	0.000332	0.000354	CcSEcCtD
Emtricitabine—Angioedema—Prednisone—prostate cancer	0.00033	0.000352	CcSEcCtD
Emtricitabine—Renal failure—Doxorubicin—prostate cancer	0.000328	0.000351	CcSEcCtD
Emtricitabine—Infection—Capecitabine—prostate cancer	0.000328	0.000351	CcSEcCtD
Emtricitabine—Neuropathy peripheral—Doxorubicin—prostate cancer	0.000327	0.00035	CcSEcCtD
Emtricitabine—Urticaria—Etoposide—prostate cancer	0.000326	0.000348	CcSEcCtD
Emtricitabine—Rhinitis—Epirubicin—prostate cancer	0.000325	0.000347	CcSEcCtD
Emtricitabine—Abdominal pain—Etoposide—prostate cancer	0.000325	0.000347	CcSEcCtD
Emtricitabine—Body temperature increased—Etoposide—prostate cancer	0.000325	0.000347	CcSEcCtD
Emtricitabine—Urinary tract infection—Doxorubicin—prostate cancer	0.000325	0.000347	CcSEcCtD
Emtricitabine—Nervous system disorder—Capecitabine—prostate cancer	0.000324	0.000346	CcSEcCtD
Emtricitabine—Hepatitis—Epirubicin—prostate cancer	0.000324	0.000346	CcSEcCtD
Emtricitabine—Thrombocytopenia—Capecitabine—prostate cancer	0.000324	0.000345	CcSEcCtD
Emtricitabine—Pharyngitis—Epirubicin—prostate cancer	0.000322	0.000343	CcSEcCtD
Emtricitabine—Skin disorder—Capecitabine—prostate cancer	0.000321	0.000343	CcSEcCtD
Emtricitabine—Urinary tract disorder—Epirubicin—prostate cancer	0.00032	0.000342	CcSEcCtD
Emtricitabine—Haematuria—Doxorubicin—prostate cancer	0.000319	0.00034	CcSEcCtD
Emtricitabine—Connective tissue disorder—Epirubicin—prostate cancer	0.000318	0.00034	CcSEcCtD
Emtricitabine—Urethral disorder—Epirubicin—prostate cancer	0.000318	0.000339	CcSEcCtD
Emtricitabine—Hepatobiliary disease—Doxorubicin—prostate cancer	0.000316	0.000337	CcSEcCtD
Emtricitabine—Nausea—Estradiol—prostate cancer	0.000315	0.000336	CcSEcCtD
Emtricitabine—Vomiting—Mitoxantrone—prostate cancer	0.000314	0.000335	CcSEcCtD
Emtricitabine—Sinusitis—Doxorubicin—prostate cancer	0.000313	0.000335	CcSEcCtD
Emtricitabine—Rash—Mitoxantrone—prostate cancer	0.000311	0.000332	CcSEcCtD
Emtricitabine—Dermatitis—Mitoxantrone—prostate cancer	0.000311	0.000332	CcSEcCtD
Emtricitabine—Musculoskeletal discomfort—Docetaxel—prostate cancer	0.000311	0.000332	CcSEcCtD
Emtricitabine—Headache—Mitoxantrone—prostate cancer	0.000309	0.00033	CcSEcCtD
Emtricitabine—Insomnia—Docetaxel—prostate cancer	0.000309	0.00033	CcSEcCtD
Emtricitabine—Myalgia—Prednisone—prostate cancer	0.000307	0.000328	CcSEcCtD
Emtricitabine—Arthralgia—Prednisone—prostate cancer	0.000307	0.000328	CcSEcCtD
Emtricitabine—Paraesthesia—Docetaxel—prostate cancer	0.000307	0.000327	CcSEcCtD
Emtricitabine—Anxiety—Prednisone—prostate cancer	0.000306	0.000327	CcSEcCtD
Emtricitabine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—prostate cancer	0.000305	0.000326	CcSEcCtD
Emtricitabine—Dyspnoea—Docetaxel—prostate cancer	0.000304	0.000325	CcSEcCtD
Emtricitabine—Hypersensitivity—Etoposide—prostate cancer	0.000303	0.000323	CcSEcCtD
Emtricitabine—Musculoskeletal discomfort—Capecitabine—prostate cancer	0.000301	0.000321	CcSEcCtD
Emtricitabine—Rhinitis—Doxorubicin—prostate cancer	0.000301	0.000321	CcSEcCtD
Emtricitabine—Dyspepsia—Docetaxel—prostate cancer	0.000301	0.000321	CcSEcCtD
Emtricitabine—Hepatitis—Doxorubicin—prostate cancer	0.0003	0.00032	CcSEcCtD
Emtricitabine—Insomnia—Capecitabine—prostate cancer	0.000299	0.000319	CcSEcCtD
Emtricitabine—Pharyngitis—Doxorubicin—prostate cancer	0.000298	0.000318	CcSEcCtD
Emtricitabine—Paraesthesia—Capecitabine—prostate cancer	0.000297	0.000317	CcSEcCtD
Emtricitabine—Urinary tract disorder—Doxorubicin—prostate cancer	0.000296	0.000316	CcSEcCtD
Emtricitabine—Gastrointestinal disorder—Docetaxel—prostate cancer	0.000295	0.000315	CcSEcCtD
Emtricitabine—Asthenia—Etoposide—prostate cancer	0.000295	0.000315	CcSEcCtD
Emtricitabine—Connective tissue disorder—Doxorubicin—prostate cancer	0.000295	0.000315	CcSEcCtD
Emtricitabine—Dyspnoea—Capecitabine—prostate cancer	0.000295	0.000315	CcSEcCtD
Emtricitabine—Fatigue—Docetaxel—prostate cancer	0.000294	0.000314	CcSEcCtD
Emtricitabine—Urethral disorder—Doxorubicin—prostate cancer	0.000294	0.000314	CcSEcCtD
Emtricitabine—Nausea—Mitoxantrone—prostate cancer	0.000293	0.000313	CcSEcCtD
Emtricitabine—Immune system disorder—Epirubicin—prostate cancer	0.000293	0.000313	CcSEcCtD
Emtricitabine—Infection—Prednisone—prostate cancer	0.000292	0.000312	CcSEcCtD
Emtricitabine—Mediastinal disorder—Epirubicin—prostate cancer	0.000292	0.000312	CcSEcCtD
Emtricitabine—Pain—Docetaxel—prostate cancer	0.000292	0.000312	CcSEcCtD
Emtricitabine—Dyspepsia—Capecitabine—prostate cancer	0.000291	0.000311	CcSEcCtD
Emtricitabine—Pruritus—Etoposide—prostate cancer	0.000291	0.00031	CcSEcCtD
Emtricitabine—Nervous system disorder—Prednisone—prostate cancer	0.000289	0.000308	CcSEcCtD
Emtricitabine—Skin disorder—Prednisone—prostate cancer	0.000286	0.000305	CcSEcCtD
Emtricitabine—Gastrointestinal disorder—Capecitabine—prostate cancer	0.000285	0.000305	CcSEcCtD
Emtricitabine—Fatigue—Capecitabine—prostate cancer	0.000285	0.000304	CcSEcCtD
Emtricitabine—Mental disorder—Epirubicin—prostate cancer	0.000284	0.000303	CcSEcCtD
Emtricitabine—Pain—Capecitabine—prostate cancer	0.000283	0.000302	CcSEcCtD
Emtricitabine—Malnutrition—Epirubicin—prostate cancer	0.000282	0.000301	CcSEcCtD
Emtricitabine—Diarrhoea—Etoposide—prostate cancer	0.000281	0.0003	CcSEcCtD
Emtricitabine—Gastrointestinal pain—Docetaxel—prostate cancer	0.000279	0.000298	CcSEcCtD
Emtricitabine—Back pain—Epirubicin—prostate cancer	0.000273	0.000291	CcSEcCtD
Emtricitabine—Dizziness—Etoposide—prostate cancer	0.000272	0.00029	CcSEcCtD
Emtricitabine—Immune system disorder—Doxorubicin—prostate cancer	0.000271	0.000289	CcSEcCtD
Emtricitabine—Gastrointestinal pain—Capecitabine—prostate cancer	0.00027	0.000289	CcSEcCtD
Emtricitabine—Mediastinal disorder—Doxorubicin—prostate cancer	0.00027	0.000289	CcSEcCtD
Emtricitabine—Abdominal pain—Docetaxel—prostate cancer	0.00027	0.000288	CcSEcCtD
Emtricitabine—Body temperature increased—Docetaxel—prostate cancer	0.00027	0.000288	CcSEcCtD
Emtricitabine—Musculoskeletal discomfort—Prednisone—prostate cancer	0.000268	0.000286	CcSEcCtD
Emtricitabine—Insomnia—Prednisone—prostate cancer	0.000266	0.000284	CcSEcCtD
Emtricitabine—Paraesthesia—Prednisone—prostate cancer	0.000264	0.000282	CcSEcCtD
Emtricitabine—Mental disorder—Doxorubicin—prostate cancer	0.000263	0.00028	CcSEcCtD
Emtricitabine—Urticaria—Capecitabine—prostate cancer	0.000263	0.00028	CcSEcCtD
Emtricitabine—Body temperature increased—Capecitabine—prostate cancer	0.000261	0.000279	CcSEcCtD
Emtricitabine—Abdominal pain—Capecitabine—prostate cancer	0.000261	0.000279	CcSEcCtD
Emtricitabine—Vomiting—Etoposide—prostate cancer	0.000261	0.000279	CcSEcCtD
Emtricitabine—Malnutrition—Doxorubicin—prostate cancer	0.000261	0.000279	CcSEcCtD
Emtricitabine—Anaemia—Epirubicin—prostate cancer	0.000261	0.000278	CcSEcCtD
Emtricitabine—Dyspepsia—Prednisone—prostate cancer	0.000259	0.000277	CcSEcCtD
Emtricitabine—Rash—Etoposide—prostate cancer	0.000259	0.000276	CcSEcCtD
Emtricitabine—Dermatitis—Etoposide—prostate cancer	0.000259	0.000276	CcSEcCtD
Emtricitabine—Headache—Etoposide—prostate cancer	0.000257	0.000275	CcSEcCtD
Emtricitabine—Fatigue—Prednisone—prostate cancer	0.000254	0.000271	CcSEcCtD
Emtricitabine—Back pain—Doxorubicin—prostate cancer	0.000253	0.00027	CcSEcCtD
Emtricitabine—Hypersensitivity—Docetaxel—prostate cancer	0.000252	0.000269	CcSEcCtD
Emtricitabine—Cough—Epirubicin—prostate cancer	0.000246	0.000263	CcSEcCtD
Emtricitabine—Asthenia—Docetaxel—prostate cancer	0.000245	0.000261	CcSEcCtD
Emtricitabine—Nausea—Etoposide—prostate cancer	0.000244	0.00026	CcSEcCtD
Emtricitabine—Hypersensitivity—Capecitabine—prostate cancer	0.000244	0.00026	CcSEcCtD
Emtricitabine—Pruritus—Docetaxel—prostate cancer	0.000242	0.000258	CcSEcCtD
Emtricitabine—Anaemia—Doxorubicin—prostate cancer	0.000241	0.000258	CcSEcCtD
Emtricitabine—Gastrointestinal pain—Prednisone—prostate cancer	0.000241	0.000257	CcSEcCtD
Emtricitabine—Arthralgia—Epirubicin—prostate cancer	0.00024	0.000256	CcSEcCtD
Emtricitabine—Myalgia—Epirubicin—prostate cancer	0.00024	0.000256	CcSEcCtD
Emtricitabine—Anxiety—Epirubicin—prostate cancer	0.000239	0.000256	CcSEcCtD
Emtricitabine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—prostate cancer	0.000239	0.000255	CcSEcCtD
Emtricitabine—Asthenia—Capecitabine—prostate cancer	0.000237	0.000253	CcSEcCtD
Emtricitabine—Urticaria—Prednisone—prostate cancer	0.000234	0.00025	CcSEcCtD
Emtricitabine—Pruritus—Capecitabine—prostate cancer	0.000234	0.00025	CcSEcCtD
Emtricitabine—Diarrhoea—Docetaxel—prostate cancer	0.000234	0.000249	CcSEcCtD
Emtricitabine—Abdominal pain—Prednisone—prostate cancer	0.000233	0.000248	CcSEcCtD
Emtricitabine—Body temperature increased—Prednisone—prostate cancer	0.000233	0.000248	CcSEcCtD
Emtricitabine—Infection—Epirubicin—prostate cancer	0.000229	0.000244	CcSEcCtD
Emtricitabine—Cough—Doxorubicin—prostate cancer	0.000228	0.000243	CcSEcCtD
Emtricitabine—Diarrhoea—Capecitabine—prostate cancer	0.000226	0.000241	CcSEcCtD
Emtricitabine—Nervous system disorder—Epirubicin—prostate cancer	0.000226	0.000241	CcSEcCtD
Emtricitabine—Dizziness—Docetaxel—prostate cancer	0.000226	0.000241	CcSEcCtD
Emtricitabine—Thrombocytopenia—Epirubicin—prostate cancer	0.000225	0.000241	CcSEcCtD
Emtricitabine—Skin disorder—Epirubicin—prostate cancer	0.000224	0.000239	CcSEcCtD
Emtricitabine—Myalgia—Doxorubicin—prostate cancer	0.000222	0.000237	CcSEcCtD
Emtricitabine—Arthralgia—Doxorubicin—prostate cancer	0.000222	0.000237	CcSEcCtD
Emtricitabine—Anxiety—Doxorubicin—prostate cancer	0.000221	0.000236	CcSEcCtD
Emtricitabine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—prostate cancer	0.000221	0.000236	CcSEcCtD
Emtricitabine—Dizziness—Capecitabine—prostate cancer	0.000219	0.000233	CcSEcCtD
Emtricitabine—Vomiting—Docetaxel—prostate cancer	0.000217	0.000232	CcSEcCtD
Emtricitabine—Hypersensitivity—Prednisone—prostate cancer	0.000217	0.000232	CcSEcCtD
Emtricitabine—Rash—Docetaxel—prostate cancer	0.000215	0.00023	CcSEcCtD
Emtricitabine—Dermatitis—Docetaxel—prostate cancer	0.000215	0.00023	CcSEcCtD
Emtricitabine—Headache—Docetaxel—prostate cancer	0.000214	0.000228	CcSEcCtD
Emtricitabine—Infection—Doxorubicin—prostate cancer	0.000212	0.000226	CcSEcCtD
Emtricitabine—Asthenia—Prednisone—prostate cancer	0.000211	0.000226	CcSEcCtD
Emtricitabine—Vomiting—Capecitabine—prostate cancer	0.00021	0.000224	CcSEcCtD
Emtricitabine—Musculoskeletal discomfort—Epirubicin—prostate cancer	0.00021	0.000224	CcSEcCtD
Emtricitabine—Nervous system disorder—Doxorubicin—prostate cancer	0.000209	0.000223	CcSEcCtD
Emtricitabine—Thrombocytopenia—Doxorubicin—prostate cancer	0.000209	0.000223	CcSEcCtD
Emtricitabine—Rash—Capecitabine—prostate cancer	0.000208	0.000222	CcSEcCtD
Emtricitabine—Pruritus—Prednisone—prostate cancer	0.000208	0.000222	CcSEcCtD
Emtricitabine—Insomnia—Epirubicin—prostate cancer	0.000208	0.000222	CcSEcCtD
Emtricitabine—Dermatitis—Capecitabine—prostate cancer	0.000208	0.000222	CcSEcCtD
Emtricitabine—Headache—Capecitabine—prostate cancer	0.000207	0.000221	CcSEcCtD
Emtricitabine—Skin disorder—Doxorubicin—prostate cancer	0.000207	0.000221	CcSEcCtD
Emtricitabine—Paraesthesia—Epirubicin—prostate cancer	0.000207	0.000221	CcSEcCtD
Emtricitabine—Dyspnoea—Epirubicin—prostate cancer	0.000205	0.000219	CcSEcCtD
Emtricitabine—Nausea—Docetaxel—prostate cancer	0.000203	0.000216	CcSEcCtD
Emtricitabine—Dyspepsia—Epirubicin—prostate cancer	0.000203	0.000216	CcSEcCtD
Emtricitabine—Diarrhoea—Prednisone—prostate cancer	0.000201	0.000215	CcSEcCtD
Emtricitabine—Gastrointestinal disorder—Epirubicin—prostate cancer	0.000199	0.000212	CcSEcCtD
Emtricitabine—Fatigue—Epirubicin—prostate cancer	0.000199	0.000212	CcSEcCtD
Emtricitabine—Pain—Epirubicin—prostate cancer	0.000197	0.00021	CcSEcCtD
Emtricitabine—Nausea—Capecitabine—prostate cancer	0.000196	0.00021	CcSEcCtD
Emtricitabine—Dizziness—Prednisone—prostate cancer	0.000195	0.000208	CcSEcCtD
Emtricitabine—Musculoskeletal discomfort—Doxorubicin—prostate cancer	0.000194	0.000207	CcSEcCtD
Emtricitabine—Insomnia—Doxorubicin—prostate cancer	0.000193	0.000206	CcSEcCtD
Emtricitabine—Paraesthesia—Doxorubicin—prostate cancer	0.000191	0.000204	CcSEcCtD
Emtricitabine—Dyspnoea—Doxorubicin—prostate cancer	0.00019	0.000203	CcSEcCtD
Emtricitabine—Gastrointestinal pain—Epirubicin—prostate cancer	0.000188	0.000201	CcSEcCtD
Emtricitabine—Dyspepsia—Doxorubicin—prostate cancer	0.000188	0.0002	CcSEcCtD
Emtricitabine—Vomiting—Prednisone—prostate cancer	0.000187	0.0002	CcSEcCtD
Emtricitabine—Rash—Prednisone—prostate cancer	0.000186	0.000198	CcSEcCtD
Emtricitabine—Dermatitis—Prednisone—prostate cancer	0.000185	0.000198	CcSEcCtD
Emtricitabine—Headache—Prednisone—prostate cancer	0.000184	0.000197	CcSEcCtD
Emtricitabine—Gastrointestinal disorder—Doxorubicin—prostate cancer	0.000184	0.000196	CcSEcCtD
Emtricitabine—Fatigue—Doxorubicin—prostate cancer	0.000184	0.000196	CcSEcCtD
Emtricitabine—Urticaria—Epirubicin—prostate cancer	0.000183	0.000195	CcSEcCtD
Emtricitabine—Pain—Doxorubicin—prostate cancer	0.000182	0.000194	CcSEcCtD
Emtricitabine—Abdominal pain—Epirubicin—prostate cancer	0.000182	0.000194	CcSEcCtD
Emtricitabine—Body temperature increased—Epirubicin—prostate cancer	0.000182	0.000194	CcSEcCtD
Emtricitabine—Nausea—Prednisone—prostate cancer	0.000175	0.000187	CcSEcCtD
Emtricitabine—Gastrointestinal pain—Doxorubicin—prostate cancer	0.000174	0.000186	CcSEcCtD
Emtricitabine—Hypersensitivity—Epirubicin—prostate cancer	0.00017	0.000181	CcSEcCtD
Emtricitabine—Urticaria—Doxorubicin—prostate cancer	0.000169	0.000181	CcSEcCtD
Emtricitabine—Body temperature increased—Doxorubicin—prostate cancer	0.000168	0.00018	CcSEcCtD
Emtricitabine—Abdominal pain—Doxorubicin—prostate cancer	0.000168	0.00018	CcSEcCtD
Emtricitabine—Asthenia—Epirubicin—prostate cancer	0.000165	0.000176	CcSEcCtD
Emtricitabine—Pruritus—Epirubicin—prostate cancer	0.000163	0.000174	CcSEcCtD
Emtricitabine—Diarrhoea—Epirubicin—prostate cancer	0.000158	0.000168	CcSEcCtD
Emtricitabine—Hypersensitivity—Doxorubicin—prostate cancer	0.000157	0.000168	CcSEcCtD
Emtricitabine—Asthenia—Doxorubicin—prostate cancer	0.000153	0.000163	CcSEcCtD
Emtricitabine—Dizziness—Epirubicin—prostate cancer	0.000152	0.000163	CcSEcCtD
Emtricitabine—Pruritus—Doxorubicin—prostate cancer	0.000151	0.000161	CcSEcCtD
Emtricitabine—Vomiting—Epirubicin—prostate cancer	0.000146	0.000156	CcSEcCtD
Emtricitabine—Diarrhoea—Doxorubicin—prostate cancer	0.000146	0.000156	CcSEcCtD
Emtricitabine—Rash—Epirubicin—prostate cancer	0.000145	0.000155	CcSEcCtD
Emtricitabine—Dermatitis—Epirubicin—prostate cancer	0.000145	0.000155	CcSEcCtD
Emtricitabine—Headache—Epirubicin—prostate cancer	0.000144	0.000154	CcSEcCtD
Emtricitabine—Dizziness—Doxorubicin—prostate cancer	0.000141	0.00015	CcSEcCtD
Emtricitabine—Nausea—Epirubicin—prostate cancer	0.000137	0.000146	CcSEcCtD
Emtricitabine—Vomiting—Doxorubicin—prostate cancer	0.000135	0.000145	CcSEcCtD
Emtricitabine—Rash—Doxorubicin—prostate cancer	0.000134	0.000143	CcSEcCtD
Emtricitabine—Dermatitis—Doxorubicin—prostate cancer	0.000134	0.000143	CcSEcCtD
Emtricitabine—Headache—Doxorubicin—prostate cancer	0.000133	0.000142	CcSEcCtD
Emtricitabine—Nausea—Doxorubicin—prostate cancer	0.000127	0.000135	CcSEcCtD
